Paper
NJC
To a solution of cholic acid (1 mmol), acid hydrazide (1 mmol), 3.80 (s, 1H), 3.36 (m, 1H), 1.05 (d, J = 6.1 Hz, 3H), 0.90 (s, 3H),
and EDCI (1.2 mmol) dissolved in DCM (10 mL), DMAP (1.2 mmol) 0.71 (s, 3H); dC (125 MHz, CDCl3 + MEOD) 175.9, 168.0, 139.3,
was added in one portion at room temperature. The reaction 132.3, 130.3 (2C), 129.8 (2C), 74.0, 72.8, 69.0, 48.0, 47.5, 43.2, 43.0,
mixture was stirred at room temperature for 8 h. After completion 41.0, 40.4, 36.8, 36.5, 35.9, 35.8, 32.8, 31.8, 31.2, 30.7, 29.6, 28.7,
of reaction, the reaction mixture was extracted with 10% methanol 27.9, 24.2, 23.1, 17.7, 14.4, 13.0; HRMS calculated for C31H45O5N2-
in DCM. The organic layer was washed with saturated aqueous ClNa 583.2905; found 583.2909.
NaHCO3, brine, and was dried over Na2SO4. The crude product
upon purification by column chromatography on silica gel yielded trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]-
4.2.6. 4-Nitro-N0-((4R)-4-((3R,5S,7R,10S,12S,13R,17R)-3,7,12-
the pure product.
phenanthren-17-yl)pentanoyl)benzo hydrazide (6). 46%; mp
4.2.1. N0-((4R)-4-((3R,5S,7R,10S,12S,13R,17R)-3,7,12-Trihydroxy- decomposes above 162 1C; nmax/cmꢀ1 3415, 3258, 3050, 2935,
10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17- 2862, 1698, 1662 and 1540; dH (500 MHz, CDCl3 + MEOD) 8.22
yl)pentanoyl)decane hydrazide (1). 57%; mp 109–110 1C; (d, J = 8.5 Hz, 2H), 8.01 (d, J = 8.5 Hz, 2H), 3.91 (s, 1H), 3.77 (s,
n
max/cmꢀ1 3405, 3269, 2922, 2854, 1694 and 1651; dH (500 MHz; 1H), 3.34 (m, 1H), 0.96 (d, J = 6.4 Hz, 3H), 0.82 (s, 3H), 0.62 (s,
CDCl3; Me4Si) 10.02 (br s, 1H), 8.98 (br s, 1H), 4.02 (br s, 1H), 3.85 3H); dC (125 MHz, CDCl3 + MEOD) 173.5, 164.3, 149.7, 137.5,
(s, 1H), 3.43 (s, 1H), 2.95 (b, 2H, OH), 1.04 (d, 3H), 0.89 (m, 6H), 128.7 (2C), 123.5 (2C), 72.9, 71.3, 68.1, 46.1, 45.7, 41.4, 41.2,
0.69 (s, 3H); dC (125 MHz; MEOD) 175.6, 175.0, 74.0, 72.8, 69.0, 39.1, 38.9, 35.0, 34.5, 34.3, 30.9, 29.7, 29.6, 29.5, 27.8, 27.3, 26.1,
48.0, 47.5, 43.1, 42.9, 41.0, 40.4, 36.8, 36.5, 35.9, 34.7, 33.0, 32.7, 23.0, 22.2, 17.0, 12.1; HRMS calculated for C31H45O7N3Na
31.7, 31.1, 30.7, 30.5, 30.4, 30.2, 29.5, 28.6, 27.8, 26.5, 24.2, 23.7, 594.3146; found 594.3120.
23.1, 17.7, 14.4, 13.0; HRMS calculated for C34H60O5N2Na
599.4392; found 599.4394.
4.3. Gelation test
4.2.2. N0((4R)-4-((3R,5S,7R,10S,12S,13R,17R)-3,7,12-Trihydroxy-
10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-
yl)pentanoyl)pentanehydrazide (2). 26%; mp 171–173 1C;
In the gelation experiments, a known weight (2 wt%) of a potential
gelator and a measured aliquot of liquid were placed into a capped
glass sample vial and the system was heated in an oil bath until the
solid was dissolved, then, the solution was cooled slowly to room
temperature in air, and finally the sample vial was inverted to look
at if the solution inside could still flow. The sample was defined as
a gel, if no flow was observed. When a gel was formed at this stage,
it was denoted as ‘‘G’’. It is to be noted that some transparent gels
can be obtained at room temperature, which were denoted as
‘‘TG’’. In some cases, a gel remains cloudy so this kind of system
has been referred to as ‘‘cloudy gels (CG)’’. For systems in which
only solution remained until the end of the tests, they were referred
to as solution (S). When the gelator of a system appeared as a
precipitate or crystals, the system was denoted as ‘‘P’’. The system,
in which the potential gelator could not be dissolved even at the
boiling point of the solvent, was called an insoluble system (I)
(please see Table 1). Gelator 1 dissolved in DCM, CHCl3 and CCl4 at
room temperature and forms transparent gel after some time while
gelator 1 dissolved in benzene and toluene near to their boiling
point and forms cloudy gel upon cooling solution. Gelator 3 forms
clear solution upon heating the solution to the boiling point.
n
max/cmꢀ1 3408, 3265, 2920, 2856, 1690 and 1652; dH (200 MHz;
CD3OD) 5.47 (s, 1H), 3.94 (br s, 1H), 3.78 (br s, 1H), 3.18 (s,
2 H),2.72 (s, 2H), 1.01–0.91 (m, 9H), 0.70 (s, 3H); dC (125 MHz;
CD3OD) 174.5, 72.9, 71.6, 70.7, 50.8, 43.8, 42.7, 41.1, 38.5, 38.3,
35.1, 33.5, 31.4, 30.5, 29.7, 28.8, 28.4, 28.1, 27.4, 27.0, 23.2, 22.4,
17.6, 12.4; m/z 546.2 (M + 39 for K).
4.2.3. N0-((R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-
Trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]-
phenanthren-17-yl)pentanoyl)palmito hydrazide (3). 39%; mp
117–118 1C; nmax/cmꢀ1 3410, 3264, 2923, 2856, 1690 and 1654;
dH (500 MHz; MeOD) 3.95 (s, 1H), 3.83 (s, 1H), 3.62 (s, 1H), 1.02
(d, 3H), 0.90 (m, 6H), 0.69 (s, 3H); dC (125 MHz; MEOD) 175.8,
175.3, 74.2, 73.0, 69.2, 48.1, 47.6, 43.3, 43.1, 41.1, 40.6, 36.9,
36.6, 36.0, 34.9, 33.2, 32.9, 31.8, 31.3, 30.9, 30.6, 30.3, 29.7, 28.8,
28.0, 26.7, 24.4, 23.9, 23.3, 17.8, 14.6, 13.1; HRMS calculated for
C
40H72O5N2Na 683.5329; found 683.5333.
4.2.4. N0-((4R)-4-((3R,5S,7R,10S,12S,13R,17R)-3,7,12-Trihydroxy-
10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-
yl)pentanoyl)isonicotino hydrazide (4). 62%; mp decomposes
above 150 1C; nmax/cmꢀ1 3411, 3250,3050, 2930, 2864, 1697
and 1659; dH (200 MHz, MEOD) 8.71 (d, J = 6 Hz, 2H), 8.1 (bs,
1H), 7.83 (d, J = 6 Hz, 2H), 6.9 (bs, 1H),5.49 (s, 2H), 3.97 (s, 1H),
3.8 (s, 1H), 3.2 (m, 3H), 1.1 (d, J = 5.4 Hz, 3 H), 0.92 (s, 3H), 0.73
(s, 3H); dC (125 MHz; MEOD) 173.6, 173.5, 149.3 (2C), 121.5 (2C),
72.5, 71.0, 67.7, 46.1, 45.9, 41.2, 41.0, 38.9, 38.7, 34.9, 34.8, 34.3,
34.0, 30.9, 30.0, 29.4, 27.6, 27.0, 25.9, 22.7, 21.9, 16.5, 11.8;
HRMS calculated for C30H46O5N3 528.3428; found 528.5432.
4.2.5. 4-Chloro-N0-((4R)-4-((3R,5S,7R,10S,12S,13R,17R)-3,7,12-
trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]-
phenanthren-17-yl)pentanoyl)benzo hydrazide (5). 44%; mp
147–148 1C; nmax/cmꢀ1 3413, 3255, 3050, 2933, 2864, 1690
and 1660; dH (500 MHz, CDCl3 + MEOD) 7.84 (d, J = 10 Hz,
2H), 7.46 (d, J = 10 Hz, 1H), 4.51 (bs, 5H), 3.96 (s, 1H),
Acknowledgements
The authors thank CSIR, New Delhi, for financial support under
ORIGIN (CSC-0108) and OSDD (HCP-0001). SGA (31/11(802)/
2013-EMR-I) and PAP (31/11(442)/2008-EMR-I) thank CSIR,
New Delhi, for a senior research fellowship. We acknowledge
the help from Central NMR facility and centre for material
characterization division of CSIR, NCL.
References
1 J.-M. Lehn, Supramolecular Chemistry. Concepts and perspectives,
VCH, Weinheim, Germany, 1995.
458 | New J. Chem., 2015, 39, 453--460
This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2015